{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:57Z","timestamp":1791216597449,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.atherosclerosis.2013.05.025","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T05:16:54Z","timestamp":1370582214000},"page":"304-309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice"],"prefix":"10.1016","volume":"229","author":[{"given":"Jing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sj\u00f6berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Tia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Secco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina K.","family":"Sukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.117.3045.505","article-title":"Mast cells and susceptibility to experimental atherosclerosis","volume":"117","author":"Constantinides","year":"1953","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1126\/science.120.3105.31","article-title":"Mast cells in human atherosclerosis","volume":"120","author":"Cairns","year":"1954","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00041433-200410000-00011","article-title":"Mast cells in vulnerable coronary plaques: potential mechanisms linking mast cell activation to plaque erosion and rupture","volume":"15","author":"Lindstedt","year":"2004","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s11883-009-0033-7","article-title":"Mast cells in atherogenesis: actions and reactions","volume":"11","author":"Kovanen","year":"2009","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/er.2011-0013","article-title":"Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases","volume":"33","author":"Xu","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib6","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.2174\/1381612811319060012","article-title":"Mast cell chymase and tryptase as targets for cardiovascular and metabolic diseases","volume":"19","author":"He","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib7","doi-asserted-by":"crossref","first-page":"e14525","DOI":"10.1371\/journal.pone.0014525","article-title":"Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils","volume":"6","author":"Zhang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1601","article-title":"Mast cells promote atherosclerosis by releasing proinflammatory cytokines","volume":"13","author":"Sun","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib9","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1161\/CIRCULATIONAHA.111.066712","article-title":"Role for cysteine protease cathepsins in heart disease: focus on biology and mechanisms with clinical implication","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12018-011-9098-2","article-title":"Cysteine protease cathepsins in atherosclerosis and abdominal aortic aneurysm","volume":"9","author":"Sj\u00f6berg","year":"2011","journal-title":"Clin Rev Bone Miner Metab"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/CIRCULATIONAHA.109.849679","article-title":"Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation","volume":"120","author":"Sun","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/CIRCRESAHA.111.243758","article-title":"Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation","volume":"108","author":"Zhang","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib13","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/ATVBAHA.112.250605","article-title":"Mast cells induce vascular smooth muscle cell apoptosis via a toll-like receptor 4 activation pathway","volume":"32","author":"den Dekker","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/01.mca.0000224420.67304.4d","article-title":"Desquamation of human coronary artery endothelium by human mast cell proteases: implications for plaque erosion","volume":"17","author":"M\u00e4yr\u00e4np\u00e4\u00e4","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib15","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.atherosclerosis.2009.07.027","article-title":"Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex\u00a0vivo","volume":"208","author":"Judstr\u00f6m","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib16","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/01.ATV.0000029782.84357.68","article-title":"Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux","volume":"22","author":"Lee","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bbalip.2010.01.011","article-title":"Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRalpha activation","volume":"1801","author":"Yeong","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib18","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1194\/jlr.M200420-JLR200","article-title":"Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux","volume":"44","author":"Lee","year":"2003","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib19","doi-asserted-by":"crossref","first-page":"9930","DOI":"10.1074\/jbc.M312476200","article-title":"Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein","volume":"279","author":"Favari","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib20","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tem.2004.03.003","article-title":"PPARs and LXRs: atherosclerosis goes nuclear","volume":"15","author":"Barish","year":"2004","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib21","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/cvr\/cvq260","article-title":"Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-\/- mice","volume":"89","author":"Bot","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib23","doi-asserted-by":"crossref","first-page":"H2612","DOI":"10.1152\/ajpheart.00879.2011","article-title":"Mast cell deficiency attenuates progression of atherosclerosis and hepatic steatosis in apolipoprotein E-null mice","volume":"302","author":"Smith","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jcb.22443","article-title":"Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation","volume":"109","author":"Heikkil\u00e4","year":"2010","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib25","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1161\/CIRCULATIONAHA.106.660472","article-title":"Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice","volume":"115","author":"Bot","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCRESAHA.109.204875","article-title":"The neuropeptide substance P mediates adventitial mast cell activation and induces intraplaque hemorrhage in advanced atherosclerosis","volume":"106","author":"Bot","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib27","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cvr\/cvs312","article-title":"Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease","volume":"97","author":"de Vries","year":"2013","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib28","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib29","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1172\/JCI200314915","article-title":"Deficiency of cathepsin S reduces atherosclerosis in LDL receptor-deficient mice","volume":"111","author":"Sukhova","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib30","doi-asserted-by":"crossref","first-page":"20809","DOI":"10.1074\/jbc.M611842200","article-title":"The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections","volume":"282","author":"Thakurdas","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.immuni.2009.08.022","article-title":"Mast cell-mediated antigen presentation regulates CD8+ T cell effector functions","volume":"31","author":"Stelekati","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib32","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.4049\/jimmunol.161.4.1939","volume":"161","author":"Compton","year":"1998","journal-title":"J\u00a0Immunol"},{"issue":"Suppl.","key":"10.1016\/j.atherosclerosis.2013.05.025_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000192771","article-title":"Treatment of asthma with DSCG in juveniles during and after hospitalization","volume":"27","author":"Streumer","year":"1970","journal-title":"Respiration"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib34","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nm.1994","article-title":"Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice","volume":"15","author":"Liu","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib35","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/01.ATV.0000174125.89058.b6","article-title":"Processes involved in the site-specific effect of probucol on atherosclerosis in apolipoprotein E gene knockout mice","volume":"25","author":"Choy","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib36","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/CIRCULATIONAHA.106.664250","article-title":"Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib37","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5551\/jat.11.79","article-title":"Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice","volume":"11","author":"Niwa","year":"2004","journal-title":"J\u00a0Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib38","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1161\/CIRCULATIONAHA.107.688523","article-title":"Cathepsin L deficiency reduces diet-induced atherosclerosis in low-density lipoprotein receptor-knockout mice","volume":"115","author":"Kitamoto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib39","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.106.633263","article-title":"Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule","volume":"114","author":"Gotsman","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib40","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1172\/JCI31344","article-title":"Proatherogenic immune responses are regulated by the PD-1\/PD-L pathway in mice","volume":"117","author":"Gotsman","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib41","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","article-title":"Immune mechanisms in atherosclerosis","volume":"21","author":"Hansson","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.05.025_bib42","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013003304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013003304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T23:20:00Z","timestamp":1715469600000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013003304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0021915013003304"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.05.025","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.05.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}